Datasets

  • UroLife study molecular subtypes

    Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours.
  • PRIDE Study questionnaire data

    In this ongoing prospective cohort study, women complete web-based questionnaires at three time points in pregnancy (at enrollment [median gestational age 10 weeks], gestational...
  • ReLife study tissue samples

    Permission is available for collection of tumour blocks.
  • POM wearables

    Wearable data of the Personalized Parkinson Project, including data obtained with a Verily watch.
  • EATRIS-Plus multi-omics data of a human reference cohort

    In this reference study, blood samples of 127 healthy individuals were analyzed with a wide range of -omics technologies. The profiling data set is publicly available.
  • PRIDE Study medication diaries

    6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants...
  • PRISMA Questionnaire data

    The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,...
  • UroLife study genome-wide germline SNP data

    Isolated DNA and genome-wide germline SNP data is available for 1213 patients.
  • The EuroTARGET cohort: A European project on TArgeted therapy in renal cell...

    EuroTARGET is a European collaborative project designed as an observational study for which patients with mRCC were recruited prospectively in 62 centers. In total, 1,210...
  • UroLife study clinical data

    Data on tumour characteristics, treatment, and recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer Registry...
  • UroLife study quality of life questionnaire

    The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis.
  • PRIDE Study paternal questionnaire data

    Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate.
  • PRIDE Study saliva samples

    Single saliva samples for cortisol analyses collected in 2012-2020 in subgroup (N~3400). Partially analyzed, remaining samples stored at -20°C.
  • ReLife study clinical data

    Data on tumour characteristics, treatment, complications, recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer...
  • PRIDE-BIOME project

    Subproject among 116 PRIDE Study participants. Gut microbiome data for maternal samples collected at gestational weeks 20 and 34, and 2 months after the estimated date of...
  • PRIDE Study pharmacy data

    Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional...
  • POM imaging data

    Imaging data of the Personalized Parkinson Project, including structural and functional MRI.
  • ReLife study food frequency questionnaire

    A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery.
  • POM biomaterials

    Biomaterials of the Personalized Parkinson Project, including blood, CSF and stool samples.
  • UroLife study food frequency questionnaire

    A 163-item Food Frequency questionnaire was completed at 6 weeks (referring to pre-diagnosis lifestyle; n=1439)) and 3 (n=1316), 15 (n=1143) en 51 months (n<589) after...